← FDA Drug Approvals (Drugs@FDA)
SEVELAMER CARBONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2017-10-26
Drug application
- FDA Application #
ANDA203860- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SEVELAMER CARBONATE
- Generic name
- SEVELAMER CARBONATE
- Active ingredients
- SEVELAMER CARBONATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- INVAGEN PHARMS
- Manufacturer
- Exelan Pharmaceuticals Inc.
- First approval
- 2017-10-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown